<?xml version="1.0" encoding="UTF-8"?>
<p>The age-specific seropositive rates of JE-NTAb in the Korean population over 15 years of age are presented in 
 <xref ref-type="fig" rid="vaccines-08-00328-f002">Figure 2</xref>. The seropositive rate was more than 95% for the age of 15 to 29 years and gradually began to decrease for the age of 30 to 54 years, reaching 75.24% for the age of 55 to 59 years, 80.82% for the age of 65 to 69 years, and 59.77% above 70 years old. For comparison, the results using the PRNT assay are displayed in 
 <xref ref-type="app" rid="app1-vaccines-08-00328">Figure S1</xref>.
</p>
